Ohba, S., Teranishi, T., Matsumura, K., Kumon, M., Kojima, D., Fujiwara, E., . . . Hirose, Y. Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy. Nature Portfolio.
Chicago Style (17th ed.) CitationOhba, Shigeo, et al. Factors Involved in Maintaining Karnofsky Performance Status (≥ 50%) in Glioblastoma, IDH-wildtype Patients Treated with Temozolomide and Radiotherapy. Nature Portfolio.
MLA (9th ed.) CitationOhba, Shigeo, et al. Factors Involved in Maintaining Karnofsky Performance Status (≥ 50%) in Glioblastoma, IDH-wildtype Patients Treated with Temozolomide and Radiotherapy. Nature Portfolio.
Warning: These citations may not always be 100% accurate.